1
|
More D, Khan N, Tekade RK, Sengupta P. An Update on Current Trend in Sample Preparation Automation in Bioanalysis: strategies, Challenges and Future Direction. Crit Rev Anal Chem 2024:1-25. [PMID: 38949910 DOI: 10.1080/10408347.2024.2362707] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/03/2024]
Abstract
Automation in sample preparation improves accuracy, productivity, and precision in bioanalysis. Moreover, it reduces resource consumption for repetitive procedures. Automated sample analysis allows uninterrupted handling of large volumes of biological samples originating from preclinical and clinical studies. Automation significantly helps in management of complex testing methods where generation of large volumes of data is required for process monitoring. Compared to traditional sample preparation processes, automated procedures reduce associated expenses and manual error, facilitate laboratory transfers, enhance data quality, and better protect the health of analysts. Automated sample preparation techniques based on robotics potentially increase the throughput of bioanalytical laboratories. Robotic liquid handler, an automated sample preparation system built on a robotic technique ensures optimal laboratory output while saving expensive solvents, manpower, and time. Nowadays, most of the traditional extraction processes are being automated using several formats of online techniques. This review covered most of the automated sample preparation techniques reported till date, which accelerated and simplified the sample preparation procedure for bioanalytical sample analysis. This article critically analyzed different developmental aspects of automated sample preparation techniques based on robotics as well as conventional sample preparation methods that are accelerated using automated technologies.
Collapse
Affiliation(s)
- Dnyaneshwar More
- National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), An Institute of National Importance, Government of India, Opp. Airforce Station, Palaj, Gandhinagar 382355, Gujarat, India
| | - Nasir Khan
- National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), An Institute of National Importance, Government of India, Opp. Airforce Station, Palaj, Gandhinagar 382355, Gujarat, India
| | - Rakesh Kumar Tekade
- National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), An Institute of National Importance, Government of India, Opp. Airforce Station, Palaj, Gandhinagar 382355, Gujarat, India
| | - Pinaki Sengupta
- National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), An Institute of National Importance, Government of India, Opp. Airforce Station, Palaj, Gandhinagar 382355, Gujarat, India
| |
Collapse
|
2
|
Häbe TT, Späth C, Schrade S, Jörg W, Süssmuth RD, Bischoff D, Luippold AH. An ultrafast and flexible liquid chromatography/tandem mass spectrometry system paves the way for machine learning driven in vivo sample processing in early drug discovery. RAPID COMMUNICATIONS IN MASS SPECTROMETRY : RCM 2021; 35:e9096. [PMID: 33837598 DOI: 10.1002/rcm.9096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/12/2021] [Revised: 04/01/2021] [Accepted: 04/02/2021] [Indexed: 06/12/2023]
Abstract
RATIONALE The low speed and low flexibility of most liquid chromatography/tandem mass spectrometry (LC/MS/MS) approaches in early drug discovery delay sample analysis from routine in vivo studies within the same day. A high-throughput platform for the rapid quantification of drug compounds in various in vivo assays was developed and established in routine bioanalysis. METHODS Automated selection of an efficient and adequate LC method was realized by autonomous sample qualification for ultrafast batch gradients (9 s/sample) or for fast linear gradients (45 s/sample) if samples required chromatography. The hardware and software components of our Rapid and Integrated Analysis System (RIAS) were streamlined for increased analytical throughput via state-of-the-art automation while maintaining high analytical quality. RESULTS Online decision-making was based on a quick assay suitability test (AST), based on a small and dedicated sample set evaluated by two different strategies. 84% of the acquired data points were within ±30% accuracy and 93% of the deviations between the lower limit of quantitation (LLOQ) values were ≤2-fold compared with standard LC/MS/MS systems. Speed, flexibility and overall automation significantly improved. CONCLUSIONS The developed platform provided an analysis time of only 10 min (batch-mode) and 47 min (gradient-mode) per standard pharmacokinetic (PK) study (62 injections). Automation, data evaluation and results handling were optimized to pave the way for machine learning based on decision-making regarding the evaluation strategy of the AST.
Collapse
Affiliation(s)
- Tim T Häbe
- Boehringer Ingelheim Pharma GmbH & Co. KG, Drug Discovery Sciences, Birkendorfer Strasse 65, Biberach an der Riss, 88397, Germany
| | - Christian Späth
- Boehringer Ingelheim Pharma GmbH & Co. KG, ISEE Infrastructure, Safety, Environment and Engineering, Birkendorfer Strasse 65, Biberach an der Riss, 88397, Germany
| | - Steffen Schrade
- Boehringer Ingelheim Pharma GmbH & Co. KG, Drug Discovery Sciences, Birkendorfer Strasse 65, Biberach an der Riss, 88397, Germany
| | - Wolfgang Jörg
- Boehringer Ingelheim Pharma GmbH & Co. KG, ISEE Infrastructure, Safety, Environment and Engineering, Birkendorfer Strasse 65, Biberach an der Riss, 88397, Germany
| | - Roderich D Süssmuth
- Institut für Chemie, Technische Universität Berlin, Strasse des 17. Juni 124, Berlin, 10623, Germany
| | - Daniel Bischoff
- Boehringer Ingelheim Pharma GmbH & Co. KG, Drug Discovery Sciences, Birkendorfer Strasse 65, Biberach an der Riss, 88397, Germany
| | - Andreas H Luippold
- Boehringer Ingelheim Pharma GmbH & Co. KG, Drug Discovery Sciences, Birkendorfer Strasse 65, Biberach an der Riss, 88397, Germany
| |
Collapse
|
3
|
Medvedovici A, Bacalum E, David V. Sample preparation for large-scale bioanalytical studies based on liquid chromatographic techniques. Biomed Chromatogr 2017; 32. [DOI: 10.1002/bmc.4137] [Citation(s) in RCA: 28] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/30/2017] [Revised: 10/24/2017] [Accepted: 10/27/2017] [Indexed: 12/30/2022]
Affiliation(s)
- Andrei Medvedovici
- Faculty of Chemistry, Department of Analytical Chemistry; University of Bucharest; Bucharest Romania
| | - Elena Bacalum
- Research Institute; University of Bucharest; Bucharest Romania
| | - Victor David
- Faculty of Chemistry, Department of Analytical Chemistry; University of Bucharest; Bucharest Romania
| |
Collapse
|
4
|
Fernandez O, Urrutia M, Bernillon S, Giauffret C, Tardieu F, Le Gouis J, Langlade N, Charcosset A, Moing A, Gibon Y. Fortune telling: metabolic markers of plant performance. Metabolomics 2016; 12:158. [PMID: 27729832 PMCID: PMC5025497 DOI: 10.1007/s11306-016-1099-1] [Citation(s) in RCA: 59] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/24/2016] [Accepted: 08/16/2016] [Indexed: 02/01/2023]
Abstract
BACKGROUND In the last decade, metabolomics has emerged as a powerful diagnostic and predictive tool in many branches of science. Researchers in microbes, animal, food, medical and plant science have generated a large number of targeted or non-targeted metabolic profiles by using a vast array of analytical methods (GC-MS, LC-MS, 1H-NMR….). Comprehensive analysis of such profiles using adapted statistical methods and modeling has opened up the possibility of using single or combinations of metabolites as markers. Metabolic markers have been proposed as proxy, diagnostic or predictors of key traits in a range of model species and accurate predictions of disease outbreak frequency, developmental stages, food sensory evaluation and crop yield have been obtained. AIM OF REVIEW (i) To provide a definition of plant performance and metabolic markers, (ii) to highlight recent key applications involving metabolic markers as tools for monitoring or predicting plant performance, and (iii) to propose a workable and cost-efficient pipeline to generate and use metabolic markers with a special focus on plant breeding. KEY MESSAGE Using examples in other models and domains, the review proposes that metabolic markers are tending to complement and possibly replace traditional molecular markers in plant science as efficient estimators of performance.
Collapse
Affiliation(s)
- Olivier Fernandez
- UMR 1332 Biologie du Fruit et Pathologie, INRA, Centre INRA de Bordeaux, 71 av Edouard Bourlaux, 33140 Villenave d’Ornon, France
| | - Maria Urrutia
- UMR 1332 Biologie du Fruit et Pathologie, INRA, Centre INRA de Bordeaux, 71 av Edouard Bourlaux, 33140 Villenave d’Ornon, France
| | - Stéphane Bernillon
- UMR 1332 Biologie du Fruit et Pathologie, INRA, Centre INRA de Bordeaux, 71 av Edouard Bourlaux, 33140 Villenave d’Ornon, France
- Plateforme Métabolome Bordeaux, CGFB, MetaboHUB-PHENOME, 33140 Villenave d’Ornon, France
| | | | | | | | - Nicolas Langlade
- UMR LIPM, INRA, CNRS, Université de Toulouse, 31326 Castanet-Tolosan, France
| | - Alain Charcosset
- UMR GQE, INRA, CNRS, Université Paris Sud, AgroParisTech, Ferme du Moulon, 91190 Gif-Sur-Yvette, France
| | - Annick Moing
- UMR 1332 Biologie du Fruit et Pathologie, INRA, Centre INRA de Bordeaux, 71 av Edouard Bourlaux, 33140 Villenave d’Ornon, France
- Plateforme Métabolome Bordeaux, CGFB, MetaboHUB-PHENOME, 33140 Villenave d’Ornon, France
| | - Yves Gibon
- UMR 1332 Biologie du Fruit et Pathologie, INRA, Centre INRA de Bordeaux, 71 av Edouard Bourlaux, 33140 Villenave d’Ornon, France
- Plateforme Métabolome Bordeaux, CGFB, MetaboHUB-PHENOME, 33140 Villenave d’Ornon, France
| |
Collapse
|
5
|
Characterization of matrix effects in developing rugged high-throughput LC-MS/MS methods for bioanalysis. Bioanalysis 2016; 8:1021-34. [PMID: 27079811 DOI: 10.4155/bio-2016-0005] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
AIM There is an ever-increasing demand for high-throughput LC-MS/MS bioanalytical assays to support drug discovery and development. RESULTS Matrix effects of sofosbuvir (protonated) and paclitaxel (sodiated) were thoroughly evaluated using high-throughput chromatography (defined as having a run time ≤1 min) under 14 elution conditions with extracts from protein precipitation, liquid-liquid extraction and solid-phase extraction. A slight separation, in terms of retention time, between underlying matrix components and sofosbuvir/paclitaxel can greatly alleviate matrix effects. CONCLUSION High-throughput chromatography, with proper optimization, can provide rapid and effective chromatographic separation under 1 min to alleviate matrix effects and enhance assay ruggedness for regulated bioanalysis.
Collapse
|
6
|
Crutchfield CA, Clarke W. Present and Future Applications of High Resolution Mass Spectrometry in the Clinic. Discoveries (Craiova) 2014; 2:e17. [PMID: 32309546 PMCID: PMC6941556 DOI: 10.15190/d.2014.9] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022] Open
Abstract
High resolution mass spectrometers have directly enabled clinical applications of high clinical utility. These types of mass spectrometers are less known to the general public than their low resolution counterparts and are often ascribed to proteomics or biomarker discovery. This perception is rapidly changing as high resolution mass spectrometers see impact in the areas of clinical toxicology, forensic toxicology, microbiology, and molecular diagnostics as routine analyzers. Applications in these areas are made possible by the unique capacity of high resolution mass spectrometers, typically time-of flight or Orbitrap instruments, to characterize analytical species with sufficient mass resolution to better resolve molecular composition than lower resolution analyzers. This capacity confers a unique source of analytical specificity. In the future, this analytical specificity will likely be well applied to other clinical applications: mass spectrometry based tissue imaging, intraoperative determination of tumor boundaries, and evaluation of metabolic flux.
Collapse
Affiliation(s)
| | - William Clarke
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
| |
Collapse
|
7
|
Automation in new frontiers of bioanalysis: a key for quality and efficiency. Bioanalysis 2012; 4:2759-62. [DOI: 10.4155/bio.12.270] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023] Open
|
8
|
Li S, Hao Q, Gounarides J, Wang YK. Full utilization of a mass spectrometer using on-demand sharing with multiple LC units. JOURNAL OF MASS SPECTROMETRY : JMS 2012; 47:1074-1082. [PMID: 22899517 DOI: 10.1002/jms.3061] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/01/2023]
Abstract
The applicability of liquid chromatography-mass spectrometry (LC/MS) is often limited by throughput. The sharing of a mass spectrometer with multiple LCs significantly improves throughput; however, the reported systems have not been designed to fully utilize the MS duty cycle, and as a result to achieve maximum throughput. To fully utilize the mass spectrometer, the number of LC units that a MS will need to recruit is application dependent and could be significantly larger than the current commercial or published implementations. For the example of a single analyte, the number may approach the peak capacity to a first degree approximation. Here, the construction of a MS system that flexibly recruits any number of LC units demanded by the application is discussed, followed by the method to port a previously developed LC/MS method to the system to fully utilize a mass spectrometer. To demonstrate the performance and operation, a prototypical MS system of eight LC units was constructed. When 1-min chromatographic separations were performed in parallel on the eight LCs of the system, the average LC/MS analysis time per sample was 10.5 s when applied to the analysis of samples in 384-well plate format. This system has been successfully used to conduct large-volume biochemical assays with the analysis of a variety of molecular entities in support of drug discovery efforts. Allowing the recruitment of the number of LC units appropriate for a given application, this system has the potential to be a plug-and-play system to fully utilize a mass spectrometer.
Collapse
Affiliation(s)
- Shu Li
- Analytical Sciences, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA.
| | | | | | | |
Collapse
|
9
|
MARS: bringing the automation of small-molecule bioanalytical sample preparations to a new frontier. Bioanalysis 2012; 4:1311-26. [DOI: 10.4155/bio.12.77] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Background: In recent years, there has been a growing interest in automating small-molecule bioanalytical sample preparations specifically using the Hamilton MicroLab® STAR liquid-handling platform. In the most extensive work reported thus far, multiple small-molecule sample preparation assay types (protein precipitation extraction, SPE and liquid–liquid extraction) have been integrated into a suite that is composed of graphical user interfaces and Hamilton scripts. Using that suite, bioanalytical scientists have been able to automate various sample preparation methods to a great extent. However, there are still areas that could benefit from further automation, specifically, the full integration of analytical standard and QC sample preparation with study sample extraction in one continuous run, real-time 2D barcode scanning on the Hamilton deck and direct Laboratory Information Management System database connectivity. Results: We developed a new small-molecule sample-preparation automation system that improves in all of the aforementioned areas. Conclusion: The improved system presented herein further streamlines the bioanalytical workflow, simplifies batch run design, reduces analyst intervention and eliminates sample-handling error.
Collapse
|
10
|
Development of a high-speed, multiplexed sample-delivery instrument for LC–MS/MS bioanalysis. Bioanalysis 2012; 4:1039-56. [DOI: 10.4155/bio.12.87] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022] Open
Abstract
Background: The number of new chemical entities and types of in vitro and in vivo samples that require bioanalysis in drug discovery is large and diverse. In addition, method development time is limited as data turnaround is the highest priority. These circumstances require that a well-defined set of bioanalysis options be available in short timeframes to triage samples for analysis. Method: The Apricot Designs Dual Arm (ADDA) instrument is an LC–MS/MS sample delivery system that features a flexible hardware design coupled with software automation to enhance throughput in LC–MS/MS bioanalysis drug discovery. The instrument can perform high-throughput LC–MS/MS (8–10 s/sample) for screening and in vitro bioanalysis, as well as multiplexed LC for traditional gradient or isocratic LC approaches. The instrument control software is designed to integrate with DiscoveryQuant™ software (AB Sciex) and a global database of MS/MS conditions. Conclusion: Development of the sample delivery platform and its application in high-throughput and gradient LC will be described.
Collapse
|
11
|
Andersen D, Rasmussen B, Linnet K. Validation of a Fully Automated Robotic Setup for Preparation of Whole Blood Samples for LC-MS Toxicology Analysis. J Anal Toxicol 2012; 36:280-7. [DOI: 10.1093/jat/bks014] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
12
|
Jiang H, Ouyang Z, Zeng J, Yuan L, Zheng N, Jemal M, Arnold ME. A User-Friendly Robotic Sample Preparation Program for Fully Automated Biological Sample Pipetting and Dilution to Benefit the Regulated Bioanalysis. ACTA ACUST UNITED AC 2012; 17:211-21. [DOI: 10.1177/2211068211429775] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
13
|
An automation-assisted generic approach for biological sample preparation and LC–MS/MS method validation. Bioanalysis 2011; 3:1975-86. [DOI: 10.4155/bio.11.178] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Background: Although it is well known that automation can provide significant improvement in the efficiency of biological sample preparation in quantitative LC–MS/MS analysis, it has not been widely implemented in bioanalytical laboratories throughout the industry. This can be attributed to the lack of a sound strategy and practical procedures in working with robotic liquid-handling systems. Results: Several comprehensive automation assisted procedures for biological sample preparation and method validation were developed and qualified using two types of Hamilton Microlab liquid-handling robots. The procedures developed were generic, user-friendly and covered the majority of steps involved in routine sample preparation and method validation. Conclusion: Generic automation procedures were established as a practical approach to widely implement automation into the routine bioanalysis of samples in support of drug-development programs.
Collapse
|
14
|
Mirnaghi FS, Chen Y, Sidisky LM, Pawliszyn J. Optimization of the Coating Procedure for a High-Throughput 96-Blade Solid Phase Microextraction System Coupled with LC–MS/MS for Analysis of Complex Samples. Anal Chem 2011; 83:6018-25. [DOI: 10.1021/ac2010185] [Citation(s) in RCA: 126] [Impact Index Per Article: 9.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- Fatemeh S. Mirnaghi
- Department of Chemistry, University of Waterloo, 200 University Avenue West, Waterloo, Ontario N2L 3G1, Canada
| | - Yong Chen
- Supelco Inc., 595 North Harrison Road, Bellefonte, Pennsylvania 16823, United States
| | - Leonard M. Sidisky
- Supelco Inc., 595 North Harrison Road, Bellefonte, Pennsylvania 16823, United States
| | - Janusz Pawliszyn
- Department of Chemistry, University of Waterloo, 200 University Avenue West, Waterloo, Ontario N2L 3G1, Canada
| |
Collapse
|
15
|
Tanaka Y, Ohkawa T, Yasui H. Development of a Novel High-Throughput Analytical Methodology, Multiple Injection Method, for Quantitative Analysis in Drug Metabolism and Pharmacokinetic Studies Using Liquid Chromatography with Tandem Mass Spectrometry. Biol Pharm Bull 2011; 34:1187-93. [DOI: 10.1248/bpb.34.1187] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
- Yukari Tanaka
- Drug Metabolism and Pharmacokinetics, Drug Developmental Research Laboratories, Shionogi & Co., Ltd
- Department of Analytical and Bioinorganic Chemistry, Division of Analytical and Physical Chemistry, Kyoto Pharmaceutical University
| | - Tomoyuki Ohkawa
- Drug Metabolism and Pharmacokinetics, Drug Developmental Research Laboratories, Shionogi & Co., Ltd
| | - Hiroyuki Yasui
- Department of Analytical and Bioinorganic Chemistry, Division of Analytical and Physical Chemistry, Kyoto Pharmaceutical University
| |
Collapse
|
16
|
Vogeser M, Kirchhoff F. Progress in automation of LC-MS in laboratory medicine. Clin Biochem 2011; 44:4-13. [DOI: 10.1016/j.clinbiochem.2010.06.005] [Citation(s) in RCA: 74] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2010] [Revised: 06/01/2010] [Accepted: 06/08/2010] [Indexed: 11/15/2022]
|
17
|
Chernetsova ES, Koryakova AG. High-performance liquid chromatography coupled to mass spectrometry for studying new pharmaceutical entities. JOURNAL OF ANALYTICAL CHEMISTRY 2010. [DOI: 10.1134/s1061934810140029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
18
|
Automated sample preparation for regulated bioanalysis: an integrated multiple assay extraction platform using robotic liquid handling. Bioanalysis 2010; 2:1023-40. [DOI: 10.4155/bio.10.55] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Background: A novel approach for regulated bioanalytical sample preparation has been developed to combine multiple types of extraction techniques into one integrated and automated sample-preparation suite that pairs a graphical user interface with the Hamilton Microlab® STAR robotic liquid handler. Results: The multi-assay sample-preparation suite is composed of three bioanalytical extraction techniques: protein precipitation, solid-phase extraction and liquid–liquid extraction. Validation data provided highly reproducible and robust results for each respective automated extraction technique. Conclusion: The user-friendly graphical user interface and modular method design provide a flexible and versatile approach for routine bioanalytical sample-preparation and is the first fully integrated multiple assay sample-preparation suite for regulated bioanalysis.
Collapse
|
19
|
Shou WZ, Zhang J. Recent development in high-throughput bioanalytical support forin vitroADMET profiling. Expert Opin Drug Metab Toxicol 2010; 6:321-36. [DOI: 10.1517/17425250903547829] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
20
|
Kothari S, Song Q, Xia Y, Fico M, Taylor D, Amy JW, Stafford G, Cooks RG. Multiplexed four-channel rectilinear ion trap mass spectrometer. Anal Chem 2009; 81:1570-9. [PMID: 19173574 DOI: 10.1021/ac8023284] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
A four-channel multiplexed mass spectrometer with rectilinear ion trap (RIT) mass analyzers was designed, constructed, and characterized. The system consists of four parallel atmospheric pressure ion (API) sources, four RIT mass analyzers, four sets of ion optical elements, and four conversion dynode detectors. The complete instrument is housed in a single vacuum manifold with a common vacuum system. It has a relatively small footprint, and costs and complexity were minimized and controls simplified by sharing the electronics and control modules among different channels. Each channel of the instrument can be operated in either positive or negative ion mode with a choice of ionization methods to improve the information content from an experiment. Also, the instrument is equipped with simultaneous data acquisition capabilities from all four channels, but the use of a common RF electronics system limits the degree to which the analyzer channels can be scanned independently. The instrument was characterized over the mass/charge range of 150 to 1300 Th. Mass misassignments in different ion traps because of machining and assembly tolerances were avoided by the application of supplementary direct current signals to each mass analyzer to correct mass offsets. A multiplexed automatic gain control (AGC) scheme was developed to control the ion population in each of the traps independently. These two features allow tandem mass spectrometry to be performed with an isolation window of 1 Th so trapping identical ions in all four channels. There are two principal modes of operation. In one, the same sample is analyzed in all four channels using different ionization methods to increase the information content of the analysis. In the other mode of operation, different samples are analyzed in all four channels with the same ionization method, so providing higher throughput. These capabilities were demonstrated by examining lipids produced by Escherichia coli and complex mixtures containing drugs of abuse.
Collapse
Affiliation(s)
- Sameer Kothari
- Department of Chemistry, Purdue University, West Lafayette, Indiana 47907-2084, USA
| | | | | | | | | | | | | | | |
Collapse
|
21
|
Bioanalytical hydrophilic interaction chromatography: recent challenges, solutions and applications. Bioanalysis 2009; 1:239-53. [DOI: 10.4155/bio.09.12] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
Hydrophilic interaction chromatography (HILIC) has, in recent years, been shown to be an important supplement to reversed-phase liquid chromatography for polar analytes. HILIC, in conjunction with tandem mass spectrometry (MS/MS), has been steadily gaining acceptance in the analysis of polar compounds from complex biological matrices. This hyphenated technique offers the advantages of improved sensitivity by employing high organic content in the mobile phase, shortened sample preparation time with direct injection of the organic-solvent extracts of biological samples and the potential for ultra-fast analysis because of low-column backpressure. This article reviews recent challenges presented by HILIC, advancements in the better understanding of retention characteristics of analytes with different mobile- and stationary-phase compositions and solutions to ion suppression and interference problems encountered in HILIC–MS/MS assays. Applications of HILIC–MS/MS are summarized, including those for pharmacokinetic studies, metabolic studies, therapeutic drug monitoring and clinical diagnostics.
Collapse
|
22
|
Yu S, Crawford E, Tice J, Musselman B, Wu JT. Bioanalysis without sample cleanup or chromatography: the evaluation and initial implementation of direct analysis in real time ionization mass spectrometry for the quantification of drugs in biological matrixes. Anal Chem 2009; 81:193-202. [PMID: 19117450 DOI: 10.1021/ac801734t] [Citation(s) in RCA: 174] [Impact Index Per Article: 11.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Two key bottlenecks in pharmaceutical bioanalysis are sample cleanup and chromatographic separations. Although multiple approaches have been developed in the past decade to either shorten or multiplex these steps, they remain the rate limiting steps as ADME (Absorption, Distribution, Metabolism, and Excretion) property screening is being routinely incorporated into the drug discovery process. In this work, a novel system incorporating an automated Direct Analysis in Real Time (DART) ionization source coupled with a triple-quadrupole mass spectrometer has been developed and evaluated for quantitative bioanalysis. This system has the capability of directly analyzing samples from their biological matrixes and therefore potentially eliminating the need for sample cleanup and chromatographic separations. A LEAP Technologies autosampler was customized to perform the automated sample introduction into the DART beam with high precision, which significantly improved the reproducibility of the method. Additional pumping was applied to the atmospheric pressure inlet on the mass spectrometer to compensate for the increased vacuum load because of the use of high-flow helium by the DART. This resulted in an improvement of detection sensitivity by a factor of 10 to 100 times. Matrix effects for a diversified class of compounds were evaluated directly from untreated raw plasma and were found to range from approximately 0.05 to 0.7. Precision and accuracy were also tested for multiple test compounds over a dynamic range of four orders of magnitude. The system has been used to analyze biological samples from both in vivo pharmacokinetic studies and in vitro microsomal/S9 stability studies, and the results generated were similar to those obtained with conventional LC/MS/MS methods. Overall, this new automated DART-triple quadrupole mass spectrometer system has demonstrated significant potential for high-throughput bioanalysis.
Collapse
Affiliation(s)
- Shaoxia Yu
- Department of Drug Metabolism and Pharmacokinetics, Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139, USA
| | | | | | | | | |
Collapse
|
23
|
Ouyang Z, Federer S, Porter G, Kaufmann C, Jemal M. Strategies to Maintain Sample Integrity Using a Liquid-Filled Automated Liquid-Handling System with Fixed Pipetting Tips. ACTA ACUST UNITED AC 2008. [DOI: 10.1016/j.jala.2007.10.007] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
There are several advantages to using liquid-filled automated liquid-handling systems equipped with reusable fixed tips for sample handling of bioanalytical assays. However, liquid-handling parameters that have not been optimized can lead to sample dilution by the system liquid of the automated liquid handler causing possible inaccuracy of sample delivery. In this investigation, liquid-handling parameters involving sample delivery, such as aspiration speed, dispense speed, partition volume, excess volume, and air gaps, were closely examined to understand their roles in the accurate delivery of the sample. Consequently, two strategies for optimization of the parameters are presented that achieve accurate sample delivery while maintaining sample integrity.
Collapse
|
24
|
Mastovska K. Chapter 6 Recent Developments in Chromatographic Techniques. FOOD CONTAMINANTS AND RESIDUE ANALYSIS 2008. [DOI: 10.1016/s0166-526x(08)00006-8] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/24/2023]
|
25
|
Livesay EA, Tang K, Taylor BK, Buschbach MA, Hopkins DF, LaMarche BL, Zhao R, Shen Y, Orton DJ, Moore RJ, Kelly RT, Udseth HR, Smith RD. Fully automated four-column capillary LC-MS system for maximizing throughput in proteomic analyses. Anal Chem 2007; 80:294-302. [PMID: 18044960 DOI: 10.1021/ac701727r] [Citation(s) in RCA: 125] [Impact Index Per Article: 7.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
We describe a four-column, high-pressure capillary liquid chromatography (LC) system for robust, high-throughput liquid chromatography-mass spectrometry (LC-MS(/MS)) analyses. This system performs multiple LC separations in parallel, but staggers each of them such that the data-rich region of each separation is sampled sequentially. By allowing nearly continuous data acquisition, this design maximizes the use of the mass spectrometer. Each analytical column is connected to a corresponding ESI emitter in order to avoid the use of postcolumn switching and associated dead volume issues. Encoding translation stages are employed to sequentially position the emitters at the MS inlet. The high reproducibility of this system is demonstrated using consecutive analyses of global tryptic digest of the microbe Shewanella oneidensis.
Collapse
Affiliation(s)
- Eric A Livesay
- Biological Sciences Division, Environmental Molecular Sciences Laboratory, Pacific Northwest National Laboratory, Richland, Washington 99354, USA
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Roddy TP, Horvath CR, Stout SJ, Kenney KL, Ho PI, Zhang JH, Vickers C, Kaushik V, Hubbard B, Wang YK. Mass Spectrometric Techniques for Label-free High-Throughput Screening in Drug Discovery. Anal Chem 2007; 79:8207-13. [PMID: 17902631 DOI: 10.1021/ac062421q] [Citation(s) in RCA: 69] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
High-throughput screening (HTS) is an important tool for finding active compounds to initiate medicinal chemistry programs in pharmaceutical discovery research. Traditional HTS methods rely on fluorescent or radiolabeled reagents and/or coupling assays to permit quantitation of enzymatic target inhibition or activation. Mass spectrometry-based high-throughput screening (MS-HTS) is an alternative that is not susceptible to the limitations imposed by labeling and coupling enzymes. MS-HTS offers a selective and sensitive analytical method for unlabeled substrates and products. Furthermore, method development times are reduced without the need to incorporate labels or coupling assays. MS-HTS also permits screening of targets that are difficult or impossible to screen by other techniques. For example, enzymes that are challenging to purify can lead to the nonspecific detection of structurally similar components of the impure enzyme or matrix of membraneous enzymes. The high selectivity of tandem mass spectrometry (MS/MS) enables these screens to proceed with low levels of background noise to sensitively discover interesting hits even with relatively weak activity. In this article, we describe three techniques that we have adapted for large-scale (approximately 175,000 sample) compound library screening, including four-way parallel multiplexed electrospray liquid chromatography tandem mass spectrometry (MUX-LC/MS/MS), four-way parallel staggered gradient liquid chromatography tandem mass spectrometry (LC/MS/MS), and eight-way staggered flow injection MS/MS following 384-well plate solid-phase extraction (SPE). These methods are capable of analyzing a 384-well plate in 37 min, with typical analysis times of less than 2 h. The quality of the MS-HTS approach is demonstrated herein with screening data from two large-scale screens.
Collapse
Affiliation(s)
- Thomas P Roddy
- Discovery Technologies, Novartis Institute for Biomedical Research, 250 Massachusetts Avenue, Cambridge, Massachusetts 02139, USA.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
27
|
Volmer DA, Sleno L, Bateman K, Sturino C, Oballa R, Mauriala T, Corr J. Comparison of MALDI to ESI on a Triple Quadrupole Platform for Pharmacokinetic Analyses. Anal Chem 2007; 79:9000-6. [DOI: 10.1021/ac7016234] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Dietrich A. Volmer
- Medical Research Council, Human Nutrition Research, Elsie Widdowson Laboratory, Cambridge, United Kingdom, Donnelly Center for Cellular and Biomolecular Research, University of Toronto, Ontario, Canada, Merck Frosst Centre for Therapeutic Research, Kirkland, Quebec, Canada, and MDS Analytical Technologies, Concord, Ontario, Canada
| | - Lekha Sleno
- Medical Research Council, Human Nutrition Research, Elsie Widdowson Laboratory, Cambridge, United Kingdom, Donnelly Center for Cellular and Biomolecular Research, University of Toronto, Ontario, Canada, Merck Frosst Centre for Therapeutic Research, Kirkland, Quebec, Canada, and MDS Analytical Technologies, Concord, Ontario, Canada
| | - Kevin Bateman
- Medical Research Council, Human Nutrition Research, Elsie Widdowson Laboratory, Cambridge, United Kingdom, Donnelly Center for Cellular and Biomolecular Research, University of Toronto, Ontario, Canada, Merck Frosst Centre for Therapeutic Research, Kirkland, Quebec, Canada, and MDS Analytical Technologies, Concord, Ontario, Canada
| | - Claudio Sturino
- Medical Research Council, Human Nutrition Research, Elsie Widdowson Laboratory, Cambridge, United Kingdom, Donnelly Center for Cellular and Biomolecular Research, University of Toronto, Ontario, Canada, Merck Frosst Centre for Therapeutic Research, Kirkland, Quebec, Canada, and MDS Analytical Technologies, Concord, Ontario, Canada
| | - Renata Oballa
- Medical Research Council, Human Nutrition Research, Elsie Widdowson Laboratory, Cambridge, United Kingdom, Donnelly Center for Cellular and Biomolecular Research, University of Toronto, Ontario, Canada, Merck Frosst Centre for Therapeutic Research, Kirkland, Quebec, Canada, and MDS Analytical Technologies, Concord, Ontario, Canada
| | - Timo Mauriala
- Medical Research Council, Human Nutrition Research, Elsie Widdowson Laboratory, Cambridge, United Kingdom, Donnelly Center for Cellular and Biomolecular Research, University of Toronto, Ontario, Canada, Merck Frosst Centre for Therapeutic Research, Kirkland, Quebec, Canada, and MDS Analytical Technologies, Concord, Ontario, Canada
| | - Jay Corr
- Medical Research Council, Human Nutrition Research, Elsie Widdowson Laboratory, Cambridge, United Kingdom, Donnelly Center for Cellular and Biomolecular Research, University of Toronto, Ontario, Canada, Merck Frosst Centre for Therapeutic Research, Kirkland, Quebec, Canada, and MDS Analytical Technologies, Concord, Ontario, Canada
| |
Collapse
|
28
|
Xu RN, Fan L, Rieser MJ, El-Shourbagy TA. Recent advances in high-throughput quantitative bioanalysis by LC–MS/MS. J Pharm Biomed Anal 2007; 44:342-55. [PMID: 17360141 DOI: 10.1016/j.jpba.2007.02.006] [Citation(s) in RCA: 349] [Impact Index Per Article: 20.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2006] [Revised: 01/31/2007] [Accepted: 02/01/2007] [Indexed: 10/23/2022]
Abstract
Liquid chromatography linked to tandem mass spectrometry (LC-MS/MS) has played an important role in pharmacokinetics and metabolism studies at various drug development stages since its introduction to the pharmaceutical industry. This article reviews the most recent advances in sample preparation, separation, and the mass spectrometric aspects of high-throughput quantitative bioanalysis of drug and metabolites in biological matrices. Newly introduced techniques such as ultra-performance liquid chromatography with small particles (sub-2 microm) and monolithic chromatography offer improvements in speed, resolution and sensitivity compared to conventional chromatographic techniques. Hydrophilic interaction chromatography (HILIC) on silica columns with low aqueous/high organic mobile phase is emerging as a valuable supplement to the reversed-phase LC-MS/MS. Sample preparation formatted to 96-well plates has allowed for semi-automation of off-line sample preparation techniques, significantly impacting throughput. On-line solid-phase extraction (SPE) utilizing column-switching techniques is rapidly gaining acceptance in bioanalytical applications to reduce both time and labor required to produce bioanalytical results. Extraction sorbents for on-line SPE extend to an array of media including large particles for turbulent flow chromatography, restricted access materials (RAM), monolithic materials, and disposable cartridges utilizing traditional packings such as those used in Spark Holland systems. In the end, this paper also discusses recent studies of matrix effect in LC-MS/MS analysis and how to reduce/eliminate matrix effect in method development and validation.
Collapse
Affiliation(s)
- Raymond Naxing Xu
- Abbott Laboratories, Department of Drug Analysis, 100 Abbott Park Road, Abbott Park, IL 60064-6126, USA.
| | | | | | | |
Collapse
|
29
|
Hutchinson JP, Setkova L, Pawliszyn J. Automation of solid-phase microextraction on a 96-well plate format. J Chromatogr A 2007; 1149:127-37. [PMID: 17418854 DOI: 10.1016/j.chroma.2007.02.117] [Citation(s) in RCA: 70] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/07/2007] [Revised: 02/23/2007] [Accepted: 02/27/2007] [Indexed: 11/20/2022]
Abstract
Studies have been performed assessing the feasibility and characterizing the automation of solid-phase microextraction (SPME) on a multi-well plate format. Four polycyclic aromatic hydrocarbons (PAHs), naphthalene, fluorene, anthracene and fluoranthene, were chosen as test analytes to demonstrate the technique due to their favorable partition coefficients, K(fw), between polydimethylsiloxane (PDMS) extraction phases and water. Four different PDMS configurations were investigated regarding their suitability. These included (i) a PDMS membrane; (ii) a multi-fiber device containing lengths of PDMS-coated flexible wire; (iii) a stainless steel pin covered with silicone hollow fiber membrane and (iv) commercial PDMS-coated flexible metal fiber assemblies. Of these configurations, the stainless steel pin covered with silicone tubing was chosen as a robust alternative. An array of 96 SPME devices that can be placed simultaneously into a 96-well plate was constructed to demonstrate the high-throughput potential when performing multiple microextractions in parallel. Different agitation methods were assessed including magnetic stirring, sonication, and orbital shaking at different speeds. Orbital shaking whilst holding the SPME device in a stationary position provided the optimum agitation conditions for liquid SPME. Once the analytes had been extracted, desorption of the analytes into an appropriate solvent was investigated. Liquid-phase SPME and solvent desorption on the multi-well plate format is shown to be a viable alternative for automated high-throughput SPME analysis compatible with both gas- and liquid-chromatography platforms.
Collapse
Affiliation(s)
- Joseph P Hutchinson
- Department of Chemistry, University of Waterloo, 200 University Avenue West, Waterloo, Ontario N2L 3G1, Canada
| | | | | |
Collapse
|
30
|
|
31
|
Eichhold TH, McCauley-Myers DL, Khambe DA, Thompson GA, Hoke SH. Simultaneous determination of dextromethorphan, dextrorphan, and guaifenesin in human plasma using semi-automated liquid/liquid extraction and gradient liquid chromatography tandem mass spectrometry. J Pharm Biomed Anal 2007; 43:586-600. [PMID: 16930908 DOI: 10.1016/j.jpba.2006.07.018] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2006] [Revised: 07/06/2006] [Accepted: 07/07/2006] [Indexed: 11/21/2022]
Abstract
A method for the simultaneous determination of dextromethorphan (DEX), dextrorphan (DET), and guaifenesin (GG) in human plasma was developed, validated, and applied to determine plasma concentrations of these compounds in samples from six clinical pharmacokinetic (PK) studies. Semi-automated liquid handling systems were used to perform the majority of the sample manipulation including liquid/liquid extraction (LLE) of the analytes from human plasma. Stable-isotope-labeled analogues were utilized as internal standards (ISTDs) for each analyte to facilitate accurate and precise quantification. Extracts were analyzed using gradient liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). Use of semi-automated LLE with LC-MS/MS proved to be a very rugged and reliable approach for analysis of more than 6200 clinical study samples. The lower limit of quantification was validated at 0.010, 0.010, and 1.0 ng/mL of plasma for DEX, DET, and GG, respectively. Accuracy and precision of quality control (QC) samples for all three analytes met FDA Guidance criteria of +/-15% for average QC accuracy with coefficients of variation less than 15%. Data from the thorough evaluation of the method during development, validation, and application are presented to characterize selectivity, linearity, over-range sample analysis, accuracy, precision, autosampler carry-over, ruggedness, extraction efficiency, ionization suppression, and stability. Pharmacokinetic data are also provided to illustrate improvements in systemic drug and metabolite concentration-time profiles that were achieved by formulation optimization.
Collapse
Affiliation(s)
- Thomas H Eichhold
- The Procter and Gamble Company, Health Care Research Center, 8700 Mason-Montgomery Road, Mason, OH 45040, USA
| | | | | | | | | |
Collapse
|
32
|
Abstract
The use of high-performance liquid chromatography combined with mass spectrometry (HPLC-MS) or tandem mass spectrometry (HPLC-MS-MS) has proven to be the analytical technique of choice for most assays used in various stages of new drug discovery. A summary of the key components of HPLC-MS systems, as well as an overview of major application areas that use this technique as part of the drug discovery process, will be described here. This review will also provide an introduction into the various types of mass spectrometers that can be selected for the multiple tasks that can be performed using LC-MS as the analytical tool. The strategies for optimizing the use of this technique and also the potential problems and how to avoid them will be highlighted.
Collapse
Affiliation(s)
- Walter A Korfmacher
- Exploratory Drug Metabolism, Department of Drug Metabolism and Pharmacokinetics, Schering-Plough Research Institute, Kenilworth, NJ 07033, USA.
| |
Collapse
|
33
|
Bonneil E, Tessier S, Carrier A, Thibault P. Multiplex multidimensional nanoLC-MS system for targeted proteomic analyses. Electrophoresis 2006; 26:4575-89. [PMID: 16358250 DOI: 10.1002/elps.200500603] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
The present work describes a dual-column and dual-sprayer LC-MS system for high-throughput proteomic analyses. This system consists of two precolumns for sample desalting and two analytical columns. Each column is terminated by a nanoelectrospray emitter mounted on a robotic arm enabling their sequential positioning in front of the sampling cone of the mass spectrometer. The effluent from each emitter is recorded in separate acquisition channels without detectable crosstalk. Gradient elution to both nanoLC columns is delivered by a single HPLC system via a flow splitter. The reproducibility of retention time and peak intensity of the present multiplex system were comparable to those obtainable using a single emitter configuration. Replicate injections of complex tryptic digests (n = 10) indicated that this system provided good reproducibility of retention time and peak intensity on both columns with RSD values of less than 0.9 and 18.6%, respectively. The application of this system is demonstrated for the monitoring of protein expression changes in U937 human monocyte cells with and without phorbol ester administration. Furthermore, we also demonstrated the use of this multiplex system in a 2-D LC configuration to increase sample loading and throughput for the analysis of biomarker samples of higher complexity. Variations in peptide abundance down to two-fold change were identified across salt fractions for spiked tryptic digests present at a level of 50 fmol in 1.5 microg of plasma samples.
Collapse
|
34
|
De Nardi C, Bonelli F. Moving from fast to ballistic gradient in liquid chromatography/tandem mass spectrometry pharmaceutical bioanalysis: Matrix effect and chromatographic evaluations. RAPID COMMUNICATIONS IN MASS SPECTROMETRY : RCM 2006; 20:2709-16. [PMID: 16921566 DOI: 10.1002/rcm.2649] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/11/2023]
Abstract
The paper describes the steps taken by the authors to move from a fast to a ballistic gradient in routine liquid chromatography/tandem mass spectrometry (LC/MS/MS) analysis of plasma samples from pharmacokinetic (PK) profiling of new chemical entities. The reduction of column dimensions from 50 x 4.6 mm to 30 x 2.1 mm followed by optimization of chromatographic separation led to a decrease in the typical runtime from 5 (fast) to 2 min (ballistic) using an API4000 tandem mass spectrometer in Turbo Ionspray mode for detection. Three analytical standards representing typical molecular structures from our sample repository were used to spike plasma from four different species (rat, dog, human and mouse). Two different approaches were used to evaluate matrix effect: post-column infusion and comparison of the peak areas of neat standards and standards spiked after extraction into different pools of plasma; the influence of PEG400 as a typical dosing vehicle was also considered. Two different protein precipitation procedures were taken into account for sample extraction prior to injection. Peak shape, width and height, selectivity and sensitivity of the method were taken into account for chromatographic evaluation. The ballistic method was successfully cross-validated with the conventional fast gradient chromatographic assay.
Collapse
Affiliation(s)
- Claudio De Nardi
- Department of Pharmacology, Istituto di Ricerche di Biologia Molecolare P. Angeletti (IRBM), Merck Sharp and Dohme Research Laboratories, Via Pontina km 30.600, 00040 Pomezia, Rome, Italy.
| | | |
Collapse
|
35
|
Batycka M, Inglis NF, Cook K, Adam A, Fraser-Pitt D, Smith DGE, Main L, Lubben A, Kessler BM. Ultra-fast tandem mass spectrometry scanning combined with monolithic column liquid chromatography increases throughput in proteomic analysis. RAPID COMMUNICATIONS IN MASS SPECTROMETRY : RCM 2006; 20:2074-80. [PMID: 16773668 DOI: 10.1002/rcm.2563] [Citation(s) in RCA: 60] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/10/2023]
Abstract
Liquid chromatography combined with electrospray ionization mass spectrometry (LC/ESI-MS) has been used successfully for the characterization of biomolecules in proteomics in the last few years. This methodology relied largely on the use of reversed-phase chromatography, in particular C18-based resins, which are suitable for separation of peptides. Here we show that polymeric [polystyrene divinylbenzene] monolithic columns can be used to separate peptide mixtures faster and at a higher resolution. For 500 fmol bovine serum albumin, up to 68% sequence coverage and Mascot Mowse scores of >2000 were obtained using a 9 min gradient on a monolithic column coupled to an ion trap mass spectrometer with ultra-fast MS/MS scan rates. In order to achieve similar results using C18 columns, it was necessary to extend gradient times to 30 min. In addition, we demonstrate the utility of this approach for the analysis of whole Escherichia coli cell lysates by one-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis (1D-SDS-PAGE) in combination with LC/MS/MS using 4 min gradients on monolithic columns. Our results indicate higher throughput capabilities of monolithic columns (3-fold gain in time or more) for conventional proteomics applications, such as protein identification and high sequence coverage usually required for detection of post-translational modifications (PTMs). Further optimization of sensitivity and quality of sequence information is discussed, in particular when combined with mass spectrometers that have very fast MS-MS/MS switching and scanning capabilities.
Collapse
Affiliation(s)
- Mariola Batycka
- Henry Wellcome Building for Molecular Physiology, Nuffield Department of Clinical Medicine, University of Oxford, Roosevelt Drive, Oxford OX3 7BN, UK
| | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Srinivas NR. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations. Biomed Chromatogr 2006; 20:383-414. [PMID: 16307470 DOI: 10.1002/bmc.594] [Citation(s) in RCA: 50] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
The development of sound bioanalytical method(s) is of paramount importance during the process of drug discovery and development culminating in a marketing approval. Although the bioanalytical procedure(s) originally developed during the discovery stage may not necessarily be fit to support the drug development scenario, they may be suitably modified and validated, as deemed necessary. Several reviews have appeared over the years describing analytical approaches including various techniques, detection systems, automation tools that are available for an effective separation, enhanced selectivity and sensitivity for quantitation of many analytes. The intention of this review is to cover various key areas where analytical method development becomes necessary during different stages of drug discovery research and development process. The key areas covered in this article with relevant case studies include: (a) simultaneous assay for parent compound and metabolites that are purported to display pharmacological activity; (b) bioanalytical procedures for determination of multiple drugs in combating a disease; (c) analytical measurement of chirality aspects in the pharmacokinetics, metabolism and biotransformation investigations; (d) drug monitoring for therapeutic benefits and/or occupational hazard; (e) analysis of drugs from complex and/or less frequently used matrices; (f) analytical determination during in vitro experiments (metabolism and permeability related) and in situ intestinal perfusion experiments; (g) determination of a major metabolite as a surrogate for the parent molecule; (h) analytical approaches for universal determination of CYP450 probe substrates and metabolites; (i) analytical applicability to prodrug evaluations-simultaneous determination of prodrug, parent and metabolites; (j) quantitative determination of parent compound and/or phase II metabolite(s) via direct or indirect approaches; (k) applicability in analysis of multiple compounds in select disease areas and/or in clinically important drug-drug interaction studies. A tabular representation of select examples of analysis is provided covering areas of separation conditions, validation aspects and applicable conclusion. A limited discussion is provided on relevant aspects of the need for developing bioanalytical procedures for speedy drug discovery and development. Additionally, some key elements such as internal standard selection, likely issues of mass detection, matrix effect, chiral aspects etc. are provided for consideration during method development.
Collapse
Affiliation(s)
- Nuggehally R Srinivas
- Drug Development, Discovery Research, Dr Reddy's Laboratories Limited, Bollaram Road, Miyapur, Hyderabad, India.
| |
Collapse
|
37
|
Kobayashi H, Ikegami T, Kimura H, Hara T, Tokuda D, Tanaka N. Properties of Monolithic Silica Columns for HPLC. ANAL SCI 2006; 22:491-501. [PMID: 16760589 DOI: 10.2116/analsci.22.491] [Citation(s) in RCA: 71] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Monolithic silica columns and their use in high peak-capacity HPLC separations are reviewed. Monolithic silica columns can potentially provide higher overall performance than particle-packed columns based on the variable external porosity and variable through-pore size/skeleton size ratios. The high permeability of monolithic silica columns resulting from the high porosity is shown to be advantageous to generate large numbers of theoretical plates with long capillary columns. High permeability together with the high stability of the network structures of silica allows their use in high-speed separations required for a second-dimension column in two dimensional HPLC. Disadvantages of monolithic silica columns are also described.
Collapse
Affiliation(s)
- Hiroshi Kobayashi
- Department of Polymer Science and Engineering, Kyoto Institute of Technology, Matsugasaki, Kyoto, Japan
| | | | | | | | | | | |
Collapse
|
38
|
Anderson L. Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J Physiol 2005; 563:23-60. [PMID: 15611012 PMCID: PMC1665562 DOI: 10.1113/jphysiol.2004.080473] [Citation(s) in RCA: 266] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2004] [Accepted: 12/16/2004] [Indexed: 11/08/2022] Open
Abstract
The key concept of proteomics (looking at many proteins at once) opens new avenues in the search for clinically useful biomarkers of disease, treatment response and ageing. As the number of proteins that can be detected in plasma or serum (the primary clinical diagnostic samples) increases towards 1000, a paradoxical decline has occurred in the number of new protein markers approved for diagnostic use in clinical laboratories. This review explores the limitations of current proteomics protein discovery platforms, and proposes an alternative approach, applicable to a range of biological/physiological problems, in which quantitative mass spectrometric methods developed for analytical chemistry are employed to measure limited sets of candidate markers in large sets of clinical samples. A set of 177 candidate biomarker proteins with reported associations to cardiovascular disease and stroke are presented as a starting point for such a 'directed proteomics' approach.
Collapse
|
39
|
Kong R. 17 LC/MS application in high-throughput adme screen. SEP SCI TECHNOL 2005. [DOI: 10.1016/s0149-6395(05)80061-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
40
|
Borges V, Yang E, Dunn J, Henion J. High-throughput liquid chromatography-tandem mass spectrometry determination of bupropion and its metabolites in human, mouse and rat plasma using a monolithic column. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 804:277-87. [PMID: 15081921 DOI: 10.1016/j.jchromb.2004.01.024] [Citation(s) in RCA: 52] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2003] [Revised: 01/07/2004] [Accepted: 01/14/2004] [Indexed: 11/28/2022]
Abstract
In the present work, a high-throughput LC/MS/MS method using a Chromolith RP-18 (50 mm x 4.6 mm) monolithic column was developed and partially validated for the determination of bupropion (BUP), an anti-depressant drug, and its metabolites, hydroxybupropion and threo-hydrobupropion (TB), in human, mouse, and rat plasma. A modern integrated liquid chromatograph and an LC/MS/MS system with a TurboIonSpray (TIS) interface were used for the positive electrospray selected reaction monitoring (SRM) LC/MS analyses. Spiked control plasma calibration standards and quality control (QC) samples were extracted by semi-automated 96-well liquid-liquid extraction (LLE) using ethyl acetate. A mobile phase consisting of 8mM ammonium acetate-acetonitrile (55:45, v/v) delivered isocratically at 5 ml/min, and split post-column to 2 ml/min directed to the TIS, provided the optimum conditions for the chromatographic separation of bupropion and its metabolites within 23s. The isotope-labeled D(6)-bupropion and D(6)-hydroxybupropion were used as internal standards. The method was linear over a concentration range of 0.25-200 ng/ml (bupropion and threo-hydrobupropion), and 1.25-1000 ng/ml (hydroxybupropion). The intra- and inter-day assay accuracy and precision were within 15% for all analytes in each of the biological matrices. The monolithic column performance as a function of column backpressure, peak asymmetry, and retention time reproducibility was adequately maintained over 864 extracted plasma injections.
Collapse
Affiliation(s)
- Virginia Borges
- Analytical Toxicology, Department of Population Medicine and Diagnostic Sciences, Cornell University, 927 Warren Drive, Ithaca, NY 14850, USA
| | | | | | | |
Collapse
|
41
|
Berna MJ, Ackermann BL, Murphy AT. High-throughput chromatographic approaches to liquid chromatographic/tandem mass spectrometric bioanalysis to support drug discovery and development. Anal Chim Acta 2004. [DOI: 10.1016/j.aca.2003.12.023] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
42
|
Benijts T, Dams R, Lambert W, De Leenheer A. Countering matrix effects in environmental liquid chromatography–electrospray ionization tandem mass spectrometry water analysis for endocrine disrupting chemicals. J Chromatogr A 2004; 1029:153-9. [PMID: 15032360 DOI: 10.1016/j.chroma.2003.12.022] [Citation(s) in RCA: 170] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
In recent years, despite the increasing success of liquid chromatography (LC) coupled to tandem mass spectrometry (MS), reports on matrix susceptibility have shown the limitations of the this powerful analytical technique. Matrix effects (MEs) result from co-eluting residual matrix components affecting the ionization efficiency of target analytes and can lead to erroneous results. The present work evaluates the matrix effect of environmental water samples on 35 endocrine disrupting chemicals (EDCs) in negative and positive LC-ESI-MS/MS. It was shown that mobile-phase additives could significantly influence matrix effects. Addition of acids resulted in a severe signal suppression (average ME%: <65%), and 1 mM ammonium formate increased the average ME% to 84%. The importance of an efficient sample clean-up and internal standardization also was demonstrated. Cleaner extracts resulted in reduced matrix effects (average ME%: 89%) and labeled internal standards proved to have a beneficial effect especially on signal reproducibility (average CV% 4.2% versus 2.6%). The results from the present work indicate that evaluation of matrix effects should become an integrated part of quantitative LC-ESI-MS/MS method development and validation.
Collapse
Affiliation(s)
- Tom Benijts
- Laboratory of Toxicology, Ghent University, Harelbekestraat 72, B-9000 Gent, Belgium
| | | | | | | |
Collapse
|
43
|
Chovan LE, Black-Schaefer C, Dandliker PJ, Lau YY. Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays. RAPID COMMUNICATIONS IN MASS SPECTROMETRY : RCM 2004; 18:3105-3112. [PMID: 15565734 DOI: 10.1002/rcm.1735] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/24/2023]
Abstract
High-throughput metabolic screening has been requested routinely to keep pace with high-throughput organic synthesis. Liquid chromatography/tandem mass spectrometry (LC/MS/MS) with a fast gradient has become the method of choice for the task due to its sensitivity and selectivity. We have developed an automated system that consists of a robotic system for in vitro incubation and a commercially available software package for automatic MS/MS method development. A short, generic LC gradient and MS conditions that are applicable to most compounds have been developed to minimize the method development time and data analysis. This system has been used to support a number of in vitro screening assays in early drug discovery phase including microsomal stability and protein binding.
Collapse
Affiliation(s)
- Linda E Chovan
- Global Pharmaceutical Research and Development, Abbott Laboratories, Advanced Technologies, Dept. R4CP, Bldg. AP52-N, 200 Abbott Park Road, Abbott Park, IL 60064-6217, USA
| | | | | | | |
Collapse
|
44
|
Kerns EH, Kleintop T, Little D, Tobien T, Mallis L, Di L, Hu M, Hong Y, McConnell OJ. Integrated high capacity solid phase extraction-MS/MS system for pharmaceutical profiling in drug discovery. J Pharm Biomed Anal 2004; 34:1-9. [PMID: 14738913 DOI: 10.1016/j.japna.2003.03.001] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
A method is described for use in analysis of samples from pharmaceutical profiling of early drug discovery compounds. The method consists of a high capacity autosampler which injects samples into one of two solid phase extraction columns operated in parallel for alternating trapping, washing and elution into a tandem quadrupole mass spectrometer operated in multiple reaction monitoring (MRM) MS/MS mode. A primary method, which is useful for 80-90% of compounds, and a secondary method, which is useful for a majority of the remaining compounds, are described. No analytical HPLC column is used and the analysis rate is approximately 50 samples/h. Specificity is obtained using MRM analysis. Application of the method for high capacity analysis of metabolic stability samples is described.
Collapse
|
45
|
Chen YL, Junga H, Jiang X, Naidong W. Simultaneous determination of theophylline, tolbutamide, mephenytoin, debrisoquin, and dapsone in human plasma using high-speed gradient liquid chromatography/tandem mass spectrometry on a silica-based monolithic column. J Sep Sci 2003. [DOI: 10.1002/jssc.200301543] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
46
|
Fung EN, Chen YH, Lau YY. Semi-automatic high-throughput determination of plasma protein binding using a 96-well plate filtrate assembly and fast liquid chromatography–tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2003; 795:187-94. [PMID: 14522023 DOI: 10.1016/s1570-0232(03)00564-6] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
A semi-automatic, high-throughput method has been developed to rapidly assess plasma protein binding of new chemical entities in drug discovery phase. New chemical entities are mixed with plasma and the unbound fractions are separated from the bound fraction by ultrafiltration in a 96-well filtrate assembly. The unbound fractions are then analyzed by fast liquid chromatography-tandem mass spectrometry (LC-MS/MS). Sample handling is automated by a robotic system. Employing a cocktail approach where multiple new chemical entities are allowed to bind to plasma proteins in the same well has further increased the throughput. We have validated the method with 12 commercially available compounds. The plasma protein binding data obtained by this method are comparable with the literature values. This method enables the determination of protein binding for 32 compounds in one single experiment instead of 1-2 compounds using the conventional methods.
Collapse
Affiliation(s)
- Eliza N Fung
- Schering-Plough Research Institute, Drug Metabolism and Pharmacokinetics, 2015 Galloping Hill Road, K-15-2-2700 Kenilworth, NJ 07033, USA
| | | | | |
Collapse
|
47
|
van de Merbel NC, Poelman H. Experiences with monolithic LC phases in quantitative bioanalysis. J Pharm Biomed Anal 2003; 33:495-504. [PMID: 14550867 DOI: 10.1016/s0731-7085(03)00297-8] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
The applicability of monolithic liquid chromatographic (LC) phases in the field of quantitative bioanalysis has been evaluated. Two existing methods with fluorescence detection (the determination of bexarotene in plasma and the determination of dextromethorphan plus metabolites in urine) were successfully transferred from a conventional reversed-phase column to a 10 cm x 4.6 mm i.d. monolith. By simply increasing the mobile phase flow-rate, run times were about 3-fold reduced, while the chromatographic resolution of the analytes remained unaffected. In both cases, a very good correlation was found between the results of clinical samples obtained with the original method and those obtained with the adapted method. Two methods with tandem mass spectrometric detection were set up. For one of these methods (nifedipine in plasma), the separation of the analyte from interfering matrix components did not need a high plate number; the resolution found on a 10-cm monolith at 6 ml/min and that on a 3-cm conventional column at 2 ml/min were comparable and achieved in the same period of time. As the validation results on both column types were similar and considering the limited compatibility of mass spectrometric detection with high solvent flow rates, the conventional column was concluded to be the best choice for this application. For the determination of estradiol in plasma, however, there was so much interfering material that needed to be separated from the analyte, that the best results were obtained with three 10-cm monolithic columns coupled in series and because of the possibility to apply a relatively high flow-rate, a reasonable run time was still achieved.
Collapse
Affiliation(s)
- N C van de Merbel
- Pharma Bio-Research Group B.V., Westerbrink 3, 9405 BJ, Assen, Netherlands.
| | | |
Collapse
|
48
|
|
49
|
Ohkawa T, Ishida Y, Kanaoka E, Takahashi K, Okabe H, Matsumoto T, Nakamoto S, Tamada J, Koike M, Yoshikawa T. A new generic column switching system for quantitation in cassette dosing using LC/MS/MS. J Pharm Biomed Anal 2003; 31:1089-99. [PMID: 12667925 DOI: 10.1016/s0731-7085(02)00649-0] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Cassette dosing is a method in which multiple drugs are administered to a single animal at the same time, and the plasma concentrations of the individual compounds are simultaneously determined. This method enables high-throughput rapid screening for pharmacokinetic assessment of new drug candidates. An available gradient method was modified for cassette dosing analysis to attain the advantages of high sensitivity and applicability to a wide range of compounds. However, two problems arose; (1). the time-consuming optimization of mobile phases for each compound group, which limited applicability and (2). the remarkable suppression of ionization by polyethyleneglycol, which is commonly used in intravenous administration. To resolve these problems, a new column switching method was established to attain wider applicability and avoid the ionization suppression. This column switching system is very simple because the trap column and the analytical column are specified and the mobile phase is selected from only two species. Method optimization requires only the selection of the mobile phase and takes only a few hours. About 200 compounds, which were administered as about 50 cassettes, were analyzed using this column switching system. Assay validation of one cassette was carried out, and good accuracy and precision were obtained. About 90% of the compounds could be determined within 20% bias. These results showed that this new column switching system for cassette dosing is accurate enough for the screening of drug candidates and offers wide applicability for various compounds. This system was shown to be very useful for the determination of cassette dosing samples, containing multiple compounds.
Collapse
Affiliation(s)
- T Ohkawa
- Drug Metabolism and Pharmacokinetics, Developmental Research Laboratories, Shionogi and Co Ltd, 3-1-1, Futaba-cho, Toyonaka, Osaka 561-0825, Japan.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
|